Trial Profile
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of ALGRX 4975 in Subjects After Total Knee Arthroplasty
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 May 2007
Price :
$35
*
At a glance
- Drugs Capsaicin (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors AlgoRx Pharmaceuticals
- 05 May 2007 Results have been reported.
- 01 Aug 2006 Status change
- 18 Dec 2005 New trial record.